GlassScriptPhysician profile
Benjamin J Knabel
NPI 1871855122
$815.26
in general payments reported to CMS, 2019-2025
18 companies · $236 in 2025
The $236 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $43.64 · 2021: $55.51 · 2023: $192 · 2024: $288 · 2025: $236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $716.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $716.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $135.08 | 2024-2025 | Farxiga |
| Lilly USA, LLC | $89.63 | 2023-2025 | Zepbound, Mounjaro, Jardiance |
| Exact Sciences Corporation | $84.54 | 2023-2024 | Cologuard Collection Kit |
| Bioventus LLC | $81.79 | 2021-2025 | Exogen Ultrasound Bone Healing System |
| Novo Nordisk INC | $67.32 | 2023-2025 | Ozempic, Rybelsus |
| Stryker Corporation | $47.24 | 2024 | Phalinx |
| Glaxosmithkline, LLC. | $46.54 | 2023-2024 | Shingrix, Arexvy, Bexsero |
| Kairos Surgical INC | $43.64 | 2019 | |
| Seqirus USA INC | $32.85 | 2024-2025 | Fluad, Flucelvax |
| Philips North America LLC | $31.63 | 2023 | |
| Davol INC. | $22.61 | 2021 | |
| Amgen INC. | $20.93 | 2025 | Evenity |
| Mylan Specialty L.P. | $20.83 | 2023 | Yupelri |
| Medtronic, INC. | $20.75 | 2023 | Venaseal |
| Bayer Healthcare Pharmaceuticals INC. | $20.60 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $19.71 | 2023 | Rexulti |
| E.R. Squibb & Sons, L.L.C. | $14.98 | 2025 | Eliquis |
| Alfasigma USA, INC. | $14.59 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Knabel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.